Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000246098

Medchemexpress LLC 1,4-bis(4,5-diphenyl-1H-imidazol-2-yl)benzene | 4051-59-6 | MFCD00231029 | 98.0% | 514.62 g·mol⁻¹ | C36H26N4 | 50 MG
SDP

Catalog No. 5000246098
Encompass_Preferred

MSX-130 is a small-molecule CXCR4 antagonist for preclinical research, reported to inhibit cancer metastasis. It is supplied as a solid with high purity and recommended for in vitro studies using DMSO preparations.

  • Targets CXCR4 and inhibits cancer metastasis.
  • High purity (98.0%) suitable for biochemical assays.
  • Soluble in DMSO at approximately 2 mg/mL with sonication and warming.
  • Powder stable at -20°C for extended storage; solutions require low-temperature storage for long-term stability.
  • Supplied as a 50 mg solid for laboratory research use.

Catalog No. 50-002-46098 Supplier Medchemexpress LLC Supplier No. HY10301050MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MSX-130 is a small-molecule CXCR4 antagonist for preclinical research, reported to inhibit cancer metastasis. It is supplied as a solid with high purity and recommended for in vitro studies using DMSO preparations.

  • Targets CXCR4 and inhibits cancer metastasis.
  • High purity (98.0%) suitable for biochemical assays.
  • Soluble in DMSO at approximately 2 mg/mL with sonication and warming.
  • Powder stable at -20°C for extended storage; solutions require low-temperature storage for long-term stability.
  • Supplied as a 50 mg solid for laboratory research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.